# Stage 7: NEW Harsh-Critic Review of Technique Changes Proposal

**Protocol version**: NEW (full 17-technique protocol with Stage 5 modifications applied — T3 scoped to strategic, Skeptic scoped to operational)

**Work under review**: `plans/technique-changes-proposal.md`

---

## Phase 1 — Pre-commitment Predictions

Before reading the proposal in detail, predicted problem areas:

1. **Untested modifications** — the proposed T3/Skeptic changes are predictions, not validated outcomes
2. **Self-referential validation** — the same process that designed techniques is evaluating them
3. **Insufficient modification specificity** — MODIFY decisions may lack precision
4. **Missing failure mode analysis** — what goes wrong if the changes are bad?
5. **Fixture representativeness** — 5 synthetic test cases may not generalize

---

## Phase 2 — Verification

### Step 1: Key Assumptions Extraction

| # | Assumption | Rating | Notes |
|---|-----------|--------|-------|
| A1 | Scope constraints on T3/Skeptic will reduce overlap from ~35% to ~15-20% | FRAGILE | Untested prediction. The 15-20% target is stated without basis. |
| A2 | 100% TP rate survives the modifications | FRAGILE | Constraining what T3 looks at could cause it to miss findings it previously caught |
| A3 | Strategic vs operational is a clean, separable distinction | FRAGILE | The data-pipeline fixture's highest-overlap findings (vendor lock-in, latency architecture) are inherently both |
| A4 | 5 fixtures are a sufficient test set | REASONABLE | Covers the verdict spectrum, but sample size is small |
| A5 | 0% FP on synthetic fixtures means 0% FP on real plans | REASONABLE | Plausible but untested on messy real-world plans |
| A6 | No new technique is needed (gap-free coverage) | REASONABLE | Testing found no gaps, but absence of evidence ≠ evidence of absence |
| A7 | Token budget remains sufficient | VERIFIED | Scope constraints reduce output, not expand it |

**Three FRAGILE assumptions (A1-A3) — all related to the T3/Skeptic DIFFERENTIATE decision.**

### Step 2: Strengthened Pre-Mortem

**Certainty framing**: An infallible crystal ball shows this proposal was executed exactly as written and was a complete fiasco. What happened?

**Failure scenarios**:

1. **Dead zone catastrophe**: A real-world plan has a critical flaw that is simultaneously a strategic mistake (wrong technology choice) and an operational failure (team can't execute it). The murder board skips it because it has operational dimensions ("operational failure modes belong in the Skeptic perspective"). The skeptic skips it because it has strategic dimensions ("not the strategic direction — that's the Murder Board's job"). The finding goes unreported. The flaw reaches production.

2. **Model over-compliance**: The scope constraint language (`"not here"`, `"that's the Murder Board's job"`) causes the LLM to aggressively self-censor. Instead of capturing ~60% of the previous findings (the non-overlapping portion), it captures ~40% because the model interprets the constraint conservatively, dropping findings it's uncertain about.

3. **Checklist/protocol desync**: The Final Checklist still says "did I attempt a murder board kill of the core thesis?" without the strategic-only qualifier. The model follows the checklist (which runs last) rather than the Step 8 instructions, effectively ignoring the scope constraint. The modification has no effect.

4. **False confidence from clean metrics**: The team sees "0% FP, 100% TP, all verdicts correct" and treats the technique set as definitively validated. In reality, 5 synthetic fixtures are a tiny sample. The first real-world deployment surfaces problems the test suite couldn't predict.

5. **Stakeholder pushback**: A reviewer looks at the proposal and asks "you had a problem that wasn't causing any harm, and you changed working code to fix it — why?" The DIFFERENTIATE approach cannot be justified by the test data, which showed the overlap was benign.

**Black swans**:

6. **Prompt interaction with future model versions**: The scope constraint language ("not here", "that's the Murder Board's job") works with the current Claude model but interacts badly with a future model update that interprets scoping language differently. The constraint becomes either too aggressive (suppresses all murder board output) or ignored entirely.

7. **Technique coupling emergence**: The cross-reference between T3 and Skeptic ("that's the Murder Board's job in Step 8") creates an implicit dependency between Phase 3 (where Skeptic runs) and Phase 2 Step 8 (where Murder Board runs). A future protocol modification that reorders phases breaks this reference.

**Multi-horizon**:

- **Day 1**: Checklist/protocol desync (scenario 3) is immediately visible. Final Checklist doesn't match Step 8 wording.
- **1 month**: Dead zone issues (scenario 1) surface on the first real-world plan with a dual-nature flaw. Model over-compliance (scenario 2) becomes visible across multiple reviews.
- **6 months**: The technique set is treated as "validated" based on 5 fixtures and never re-tested. Drift accumulates as the protocol is used on increasingly diverse plans.

**Plan coverage check**:
- Scenario 1 (dead zone): NOT addressed
- Scenario 2 (over-compliance): NOT addressed
- Scenario 3 (checklist desync): NOT addressed — genuine oversight
- Scenario 4 (false confidence): Partially addressed in §6 ("Predicted after changes")
- Scenario 5 (stakeholder pushback): NOT addressed
- Scenario 6 (future model versions): NOT addressed (acceptable — black swan)
- Scenario 7 (technique coupling): NOT addressed

### Step 3: Dependency Audit

Dependencies verified (same as OLD review):
- §1 → Stage 1-4 results: VERIFIED
- §2 → §1 decisions: VERIFIED
- §5 → §2 wording: VERIFIED
- §6 → §2 changes: VERIFIED

Additional finding: §5 depends on the assumption that "all other protocol text remains identical" but doesn't verify cross-references (Final Checklist, SKILL.md, Success Criteria).

### Step 4: Ambiguity Scan

| Quote | Interpretation A | Interpretation B | Risk |
|-------|-----------------|-----------------|------|
| `"targeting the problem framing, technology choice, or architectural direction, not implementation gaps"` | Illustrative examples of strategic scope | Exhaustive list — only these three categories are valid murder board targets | If B: scope too narrow, misses strategic issues outside these categories |
| `"operational failure modes belong in the Skeptic perspective (Phase 3), not here"` | Soft guideline — murder board can mention operational aspects if they're part of a strategic argument | Hard rule — any operational content in murder board output is a protocol violation | If B: dead zone for dual-nature issues |
| `"Zero impact on true positive rate"` (§2.3) | Strong claim based on evidence that all overlap-zone findings were independently discovered | Aspirational claim that hasn't been tested with the modified prompts | If latter: the proposal overstates confidence |

### Step 5: Feasibility Check

The prompt changes in §2 are concrete and executable. An executor can apply them directly.

Missing: verification that the Final Checklist, Success Criteria section, and SKILL.md don't need corresponding updates. The executor would need to check these independently.

### Step 6: Rollback Analysis

Not documented in the proposal. Implicit rollback: git revert two prompt edits. Trivial but should be stated.

### Step 7: Devil's Advocate + Socratic Deconstruction

**Socratic why-chains on the key decision (DIFFERENTIATE rather than KEEP or MERGE)**:

**Why differentiate T3 and Skeptic rather than keep the ~35% overlap?**
→ "Because ~35% exceeds the 30% redundancy threshold established in the testing plan."

**Why is the 30% threshold the right threshold?**
→ "Because the testing plan set it as the criteria for suggesting consolidation."

**Why should we trust that threshold?**
→ The chain terminates here. The 30% threshold was set a priori in the testing plan without empirical basis. There is no evidence that 35% overlap causes problems — in fact, the test results show it causes zero problems (0% FP, correct verdicts, no escalation issues). **The reasoning chain collapses at level 3 into an unjustified axiom: "30% was the threshold we set, so 35% is a problem."**

**Logical fallacy scan**:
- **Begging the question**: The proposal assumes 35% overlap is a problem because it exceeds a threshold, then proposes a fix for this "problem." But the threshold was arbitrary, and the evidence shows the overlap is benign. The finding is circular: "we should fix the overlap because it exceeds our threshold for fixing overlap."
- **False dichotomy**: §1 presents three options (KEEP/MODIFY/MERGE) but doesn't consider a fourth: MODIFY the threshold rather than MODIFY the techniques. If the 30% threshold is wrong (as the evidence suggests), updating the threshold is a simpler fix.

### Step 8: Murder Board

**Thesis-level attack on the proposal's strategic rationale**:

This proposal's core strategic claim — that T3/Skeptic overlap at ~35% is a problem requiring intervention — is contradicted by its own evidence. The overlap produced zero false positives, zero incorrect verdicts, and zero escalation issues. The proposal is solving a non-problem by introducing scope constraints that create a genuine new failure mode (the dead zone for dual-nature findings). The cure is riskier than the disease, and the disease was asymptomatic.

**Assessment: COMPELLING.** The proposal's own evidence argues against its central modification. Every metric that matters (TP rate, FP rate, verdict accuracy, escalation calibration) was perfect WITH the overlap. The only justification for fixing it is that it exceeds an arbitrary, pre-set threshold. This is a structural weakness — the proposal hasn't earned the right to modify working techniques.

### Step 9: Competing Alternatives (ACH-lite)

**Alternative 1: KEEP (accept ~35% overlap)**
- Evidence for: all metrics are perfect with the overlap; the overlap represents convergent evidence; zero risk of regression
- Evidence against: exceeds the 30% threshold
- Diagnostic value of 30% threshold: LOW — the threshold was set without empirical basis

**Alternative 2: MODIFY the threshold, not the techniques**
- Evidence for: the test results suggest 35% overlap is benign; updating the threshold to 40% would make T3/Skeptic compliant with zero code changes; eliminates all risk of dead zones or over-compliance
- Evidence against: could be seen as "moving the goalposts"
- Diagnostic value: HIGH — directly addresses the mismatch between evidence and threshold

**Assessment**: The proposal's evidence is **non-diagnostic** — it supports KEEP and threshold-MODIFY at least as strongly as it supports DIFFERENTIATE. The proposal chose the highest-risk option without ruling out the lower-risk alternatives.

### Step 10: Backcasting

**Goal**: Reduce T3/Skeptic overlap from ~35% to ~15-20% without reducing true positive rate or increasing false positive rate.

**Working backward**:
- For overlap to drop to ~15-20%, the murder board must stop generating operational findings → requires the scope constraint to work as intended
- For the scope constraint to work, the model must correctly classify findings as "strategic" vs "operational" → requires the strategic/operational boundary to be clear and enforceable
- For the boundary to be clear, strategic and operational concerns must be separable → **THIS LINK IS BROKEN**: the data-pipeline fixture showed ~60% overlap precisely because the same issues (vendor lock-in, latency architecture) are inherently both strategic AND operational

**Broken chain**: The proposal's goal requires a separable strategic/operational boundary, but the evidence shows this boundary is fuzzy at exactly the points where it matters most (severe findings in weak plans).

---

## Phase 3 — Multi-Perspective Review

### Executor
"Can I implement these changes without hitting an undocumented wall?"

The prompt changes are clear and implementable. However:
- The Final Checklist needs updating and isn't flagged
- The Success Criteria section references murder board without the new scope qualifier
- SKILL.md may need changes — not checked
- The cross-reference between Skeptic ("that's the Murder Board's job in Step 8") assumes the reader has read Step 8 — in the protocol, Phase 3 (Skeptic) runs BEFORE Phase 2 Step 8 is complete. Is this a problem?

### Stakeholder
"Does this solve the right problem?"

The overlap wasn't causing harm by any measured metric. The proposal is optimizing for a process metric (overlap %) rather than an outcome metric (review quality). A stakeholder would ask: "Show me a case where the overlap caused a worse review." The proposal cannot produce one.

### Skeptic (operational focus)
"What will go wrong when a team actually implements this?"

The most likely operational failure: the scope constraints cause the model to second-guess itself at the boundary between strategic and operational analysis. Instead of producing a clean, constrained output, the model produces a hedged, uncertain output that's less useful than the unconstrained version. This is not detectable from the proposal — it requires testing the modified prompts.

---

## Phase 4 — Gap Analysis

**What's Missing**:

1. **No test of modified prompts**: The proposal predicts overlap reduction but doesn't validate it. This is the single biggest gap.
2. **No handling of dual-nature findings**: Issues that are both strategic and operational have no explicit owner in the modified protocol.
3. **No risk comparison**: KEEP vs DIFFERENTIATE vs MERGE risk profiles are not compared.
4. **No updated Final Checklist**: The checklist references the old murder board scope.
5. **No SKILL.md review**: The skill documentation may reference murder board or skeptic scope.
6. **No threshold justification**: The 30% redundancy threshold that triggers the entire modification is never justified.
7. **No discussion of "when to re-test"**: The proposal doesn't specify when or how the technique set should be re-validated after real-world use.

---

## Phase 4.5 — Self-Audit

### Part A: False Positive Check

| Finding | Confidence | Author could refute? | Flaw or preference? |
|---------|-----------|---------------------|---------------------|
| Murder board attack (proposal solves non-problem) | HIGH | PARTIALLY — could argue threshold compliance matters as process discipline | FLAW |
| Socratic collapse (30% threshold is unjustified axiom) | HIGH | PARTIALLY — could argue a priori thresholds are standard methodology | FLAW |
| Dead zone for dual-nature findings | MEDIUM | PARTIALLY — could argue model uses judgment at boundaries | FLAW |
| Backcasting broken chain (strategic/operational not separable) | HIGH | NO — data-pipeline evidence directly supports this | FLAW |
| No test of modified prompts | HIGH | NO — genuinely not tested | FLAW |
| No Final Checklist update | HIGH | NO — genuinely missing | FLAW |
| Technique coupling via cross-reference | LOW | YES — future protocol changes would naturally update cross-references | Move to Open Questions |

Moved "technique coupling" to Open Questions.

### Part B: Consider-the-Opposite (false negative check)

**§1 Summary Table — 5 KEEP decisions**: Are these genuinely correct? Could any of the KEEP techniques be hiding a problem the tests didn't catch?

- T1 (Pre-Mortem): The 20% overlap with T5 is exactly at the threshold boundary. The proposal rounds favorably — `"~20%"` could be 22% or 18%. This is a minor concern but worth noting.
- T4 (ACH-lite): The proposal shows strong evidence for keeping this. No hidden flaw found.
- T5 (Backcasting): Same boundary concern as T1 re: overlap with T1.
- T6 (Consider-the-Opposite): Solid evidence. No hidden flaw found.
- T7 (Verdict Challenge): Solid evidence. No hidden flaw found.

**§6 Expected Impact — all metrics predicted unchanged or improved**: This section is suspiciously optimistic. Every prediction is positive. For a modification that changes how two techniques operate, zero negative predictions is unrealistic. The consider-the-opposite check confirms: §6 should include at least one "risk" row alongside the "predicted improvement" rows.

---

## Phase 4.75 — Realist Check

### Murder Board finding (proposal solves a non-problem)
1. Realistic worst case: modifications make the protocol marginally worse on dual-nature findings.
2. Mitigating factor: 15 other techniques provide overlapping coverage; changes are trivially revertible.
3. Detection: would surface in first real-world use on a plan with dual-nature flaws.
4. Proportional? Yes — this is a genuine strategic concern. The proposal modifies working techniques without evidence that the overlap is harmful.

**Rating: MAJOR** (retained)

### Socratic finding (30% threshold unjustified)
1. Realistic worst case: the threshold is indeed arbitrary, but following it as process discipline isn't harmful.
2. Mitigating factor: the modification itself is small and revertible.
3. Detection: not really detectable — this is a reasoning quality issue, not a runtime issue.
4. Proportional? The finding is about the proposal's reasoning, not its operational impact.

**Downgraded: MAJOR → MINOR.** Mitigated by: even if the threshold is arbitrary, the resulting modification is small and reversible. The reasoning weakness doesn't cause operational harm.

### Dead zone finding
1. Realistic worst case: a dual-nature finding gets weaker coverage in one specific review.
2. Mitigating factor: 15 other techniques provide coverage; the model likely uses judgment at boundaries despite the constraint language.
3. Detection: would show up as a missed or weakened finding.
4. Proportional? MEDIUM risk — speculative but credible.

**Rating: MAJOR** (retained — this is a new failure mode the modifications create)

### Backcasting finding (strategic/operational not separable)
1. Realistic worst case: the scope constraint is unenforceable because the categories aren't cleanly separable, making the modification either ineffective or harmful.
2. Mitigating factor: the model will likely apply reasonable judgment rather than strict categorization.
3. Detection: overlap measurement on next test run.
4. Proportional? This is a structural concern about the modification's design.

**Rating: MAJOR** (retained — directly challenges the modification's feasibility)

### No test of modified prompts
1. Realistic worst case: the modifications have an unexpected effect discovered only after deployment.
2. Mitigating factor: the modifications are small scope constraints, not fundamental redesigns.
3. Detection: first test run with modified prompts.
4. Proportional? Yes — the absence of validation is a genuine gap.

**Rating: MAJOR** (retained)

---

## ESCALATION CHECK

- CRITICAL findings: 0
- MAJOR findings: 4
- Pattern: all 4 MAJOR findings relate to the same issue (the T3/Skeptic DIFFERENTIATE decision and its untested consequences)

**3+ MAJOR findings → ESCALATE to ADVERSARIAL mode.**

### Adversarial Expansion

Expanding scope to challenge the KEEP decisions:

**T2 (Socratic Deconstruction) — KEEP**: The proposal claims T2 is the "only technique that directly attacks reasoning quality." But the Skeptic perspective also attacks reasoning ("Is the rejection rationale sound, or was it hand-waved?"). The uniqueness claim is overstated. However, T2's why-chains and fallacy scans are structurally distinct from the Skeptic's general questioning. **Finding: The uniqueness claim is slightly overstated but the KEEP decision is still correct.** No finding generated.

**T1/T5 overlap at "~20%"**: The proposal rounds this as acceptable, but the data-pipeline fixture showed ~40% overlap between T1 and T5. The aggregate ~20% is pulled down by low-overlap fixtures. On the most important fixture type (severely flawed plans), the overlap is twice the threshold. **Finding: The ~20% aggregate masks a 40% outlier on the data-pipeline fixture.** However, the proposal explicitly acknowledges this in §1 and explains it as convergent evidence from severe structural gaps. The finding is preempted. No new finding generated.

**Adversarial mode did not surface additional major findings.** The KEEP decisions are sound.

---

## Phase 5 — Synthesis + Verdict Challenge

## VERDICT: REVISE

**Overall Assessment**: The proposal is well-structured and the 5 KEEP decisions are thoroughly supported. However, the 2 MODIFY decisions — the only changes actually proposed — rest on an unjustified threshold, create a new failure mode (dead zone for dual-nature findings), and have not been validated with the modified prompts. The proposal is solving a non-problem: the ~35% overlap produced zero false positives, zero incorrect verdicts, and zero escalation issues. The testing data argues for KEEP, not DIFFERENTIATE.

**Pre-commitment Predictions vs Actuals**:
- Predicted: untested modifications → Found: yes (MAJOR)
- Predicted: self-referential validation → Found: partially (Open Question)
- Predicted: insufficient modification specificity → Found: no — the prompt changes are precise
- Predicted: missing failure mode analysis → Found: yes — no dead zone analysis, no risk comparison
- Predicted: fixture representativeness → Found: minor concern only

**Critical Findings**: None.

**Major Findings**:

1. **Proposal solves a non-problem** (Murder Board + ACH-lite finding) — The ~35% T3/Skeptic overlap produced 0 false positives, 0 incorrect verdicts, and 0 escalation issues across all 5 fixtures. The only justification for modifying working techniques is that the overlap exceeds an arbitrary 30% threshold. The KEEP and threshold-adjustment alternatives are lower-risk and equally supported by the evidence.
   - Confidence: HIGH
   - Evidence: §2.3 claims `"Zero impact on true positive rate"` and `"Zero impact on false positive rate"` — if both metrics are predicted unchanged, the modification produces zero measurable benefit while introducing risk.
   - Why this matters: Modifying working systems without evidence of harm violates the principle of minimal change. The proposal creates risk (dead zone, over-compliance) to achieve a cosmetic improvement (overlap reduction).
   - Fix: Either (a) change the decision to KEEP and update the 30% threshold to 40% based on the empirical evidence, or (b) add a validation step — re-run data-pipeline and weak-justification with modified prompts and measure actual overlap, TP, and FP before finalizing.

2. **Dead zone for dual-nature findings** (Pre-mortem + Backcasting finding) — The scope constraints create mutual exclusion: murder board is told operational findings "belong in the Skeptic perspective," and the Skeptic is told strategic findings are "the Murder Board's job." Findings that are both strategic AND operational — empirically the most common high-overlap findings (data-pipeline at ~60%) — have no clear owner.
   - Confidence: HIGH
   - Evidence: Stage 4 data shows `"T3 and Skeptic overlap most on the data-pipeline fixture (~40%)"` — these overlapping findings are precisely the dual-nature ones. The modification's scope constraints would divide ownership of findings that are inherently indivisible.
   - Why this matters: The highest-overlap findings are also the highest-severity ones. Creating a scope boundary at this exact point risks weakening coverage on the most important findings.
   - Fix: If proceeding with DIFFERENTIATE, add explicit guidance: "If a finding is genuinely both strategic and operational, include it in the murder board output and note that it has operational dimensions the Skeptic should also examine." This eliminates the dead zone at the cost of accepting some continued overlap on dual-nature issues.

3. **No validation of modified prompts** — The proposal predicts overlap reduction to ~15-20% but this prediction is never tested. The entire rationale depends on an outcome that hasn't been measured.
   - Confidence: HIGH
   - Evidence: §2.3 says `"should reduce overlap from ~35% to ~15-20%"` — this is explicitly a prediction ("should"), not a measurement.
   - Why this matters: The modification's success criterion is an untested prediction. Without validation, the proposal is shipping a change with unknown impact.
   - Fix: Re-run at least data-pipeline (highest overlap) and clean-baseline (FP control) with the modified prompts before finalizing.

4. **Broken backcasting chain — strategic/operational boundary is not cleanly separable** — The proposal assumes the murder board can be cleanly scoped to "strategic" and the Skeptic to "operational." But the Stage 4 evidence shows the highest-overlap findings exist at the intersection of both categories.
   - Confidence: HIGH
   - Evidence: The data-pipeline fixture's overlapping findings (vendor lock-in, latency architecture, format mismatch) are simultaneously strategic mistakes AND operational risks. They cannot be cleanly assigned to one category.
   - Why this matters: If the boundary is fuzzy, the scope constraint is either unenforceable (model ignores it) or harmful (model drops valid findings). Neither outcome achieves the proposal's goal.
   - Fix: Acknowledge the fuzzy boundary and either (a) switch to KEEP or (b) use a softer constraint: "Prefer strategic arguments" rather than "operational failure modes belong in the Skeptic perspective, not here."

**Minor Findings**:

1. Final Checklist doesn't reflect the new murder board scope constraint — `"did I attempt a murder board kill of the core thesis?"` should be updated.
2. SKILL.md not checked for corresponding references that need updating.
3. §6 Expected Impact is entirely positive — no risk rows or potential negative outcomes are discussed.
4. The 30% redundancy threshold is never justified or cited. It appears in the testing plan as a given.
5. T1/T5 overlap is "~20%" in aggregate but 40% on data-pipeline — the aggregate masks a significant outlier that is acknowledged but could be more prominently flagged.

**What's Missing**:
- Validation run of modified prompts on at least 2 fixtures
- Explicit handling of dual-nature (strategic + operational) findings
- Risk comparison: KEEP vs DIFFERENTIATE vs MERGE with pros/cons/risk profiles
- Updated Final Checklist
- SKILL.md review
- At least one negative/risk prediction in §6
- Threshold justification (why 30%?)
- Re-validation plan for real-world deployment

**Ambiguity Risks**:
- `"not implementation gaps"` → Is "technology choice that fails in implementation" strategic or operational? Both interpretations are valid.
- `"operational failure modes belong in the Skeptic perspective (Phase 3), not here"` → Hard rule or soft guideline? The "not here" language reads as a hard rule.

**Multi-Perspective Notes**:
- Executor: Prompt changes are clear and implementable. But the Final Checklist, Success Criteria, and SKILL.md need verified alignment.
- Stakeholder: The proposal fixes an overlap that wasn't causing measurable harm. The stakeholder would prefer evidence that the overlap is harmful before approving changes.
- Skeptic: The most likely operational failure is the dead zone — dual-nature findings getting weaker coverage because each technique defers to the other. This is not testable from the proposal alone; it requires running the modified prompts.

**Verdict Justification**: REVISE because the proposal's 5 KEEP decisions are well-supported but its 2 MODIFY decisions have structural weaknesses. The core issue is that the modification solves a non-problem (benign overlap) by introducing a new risk (dead zone for dual-nature findings), and the predicted improvement is unvalidated. The fix is straightforward: either change the decision to KEEP (and update the threshold), or add a validation step and explicit dead-zone handling. Review escalated to ADVERSARIAL mode (4 MAJOR findings, all related to the same structural issue). Adversarial expansion confirmed the KEEP decisions are sound; no additional findings generated.

**Verdict Challenge**: "What's the best case that this should be one tier harsher — REJECT?"
- The case for REJECT: the proposal's central modification is contradicted by its own evidence, creates a new failure mode, and hasn't been tested. This is a pattern of "change for the sake of change" that undermines the integrity of the testing pipeline.
- Counter-argument: the modifications are small (two prompt edits), trivially revertible, and the 5 KEEP decisions (which represent 5/7 of the proposal's substance) are solid. The proposal's testing methodology and evidence presentation are excellent. REJECT would be disproportionate to the flaw.
- **Verdict holds at REVISE.** The MODIFY decisions need revision; the proposal as a whole does not need to be rejected.

**Open Questions**:
- Is the testing pipeline self-referential in a way that undermines its conclusions? The same analytical process designed, tested, and is now modifying the techniques.
- Would a 40% redundancy threshold be more empirically justified than 30%, given that 35% overlap caused zero problems?
- Could a softer constraint ("prefer strategic arguments in the murder board") achieve overlap reduction without creating a dead zone?
